RELAPSE
Clinical trials for RELAPSE explained in plain language.
Never miss a new study
Get alerted when new RELAPSE trials appear
Sign up with your email to follow new studies for RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New program helps men in pakistan avoid drug relapse
Disease control CompletedThis study tested a culturally adapted relapse prevention program (RPM-08) for men with substance use disorder in Pakistan. 70 participants attended eight weekly group sessions alongside their usual treatment. The goal was to see if the program could lower the risk of relapse com…
Matched conditions: RELAPSE
Phase: NA • Sponsor: Universiti Sains Malaysia • Aim: Disease control
Last updated May 17, 2026 00:51 UTC
-
New pill shows promise for tough blood cancers in early trial
Disease control CompletedThis early-phase study tested an experimental oral drug called LP-108, given alone or with another drug (azacitidine), in 32 adults whose myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia had returned or stopped responding to treatment. The mai…
Matched conditions: RELAPSE
Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated May 17, 2026 00:47 UTC
-
Immune cell therapy shows promise for Tough-to-Treat lymphoma
Disease control CompletedThis study tested a new treatment using specially engineered immune cells (CD19 CAR T cells) in 20 adults with relapsed or hard-to-treat B-cell lymphoma. The cells were given in three doses over three days. The main goal was to check safety and see how well the treatment worked. …
Matched conditions: RELAPSE
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 17, 2026 00:44 UTC